```html

Quinolone‑Associated Tendinopathy

What is Quinolone‑Associated Tendinopathy?

Quinolone‑associated tendinopathy is a condition in which the tendons – the fibrous cords that attach muscle to bone – become inflamed, weakened, or rupture after taking a fluoroquinolone antibiotic. Fluoroquinolones (often simply called “quinolones”) are broad‑spectrum antibiotics used for respiratory, urinary‑tract, gastrointestinal, and skin infections. While they are effective, they can interfere with collagen synthesis and tendon cell metabolism, leading to pain, swelling, and sometimes sudden tendon rupture. The most commonly affected tendon is the Achilles tendon, but the rotator cuff, biceps, hand‑wrist extensors, and patellar tendon can also be involved.

Most cases develop within days to weeks of starting therapy, but delayed presentations up to several months after discontinuation have been reported. The risk is higher in older adults, patients taking corticosteroids, and those with certain medical conditions (see below).

Sources: Mayo Clinic; FDA drug safety communications; CDC; National Institutes of Health (NIH) – MedlinePlus.

Common Causes

Quinolone‑associated tendinopathy is specifically triggered by exposure to fluoroquinolone antibiotics, but several factors increase susceptibility. The table below lists the most important contributors:

• Fluoroquinolone drugs – e.g., ciprofloxacin, levofloxacin, moxifloxacin, ofloxacin, gatifloxacin, and delafloxacin.
• Advanced age – patients > 60 years have a 2–3‑fold higher risk.
• Concurrent systemic corticosteroid use – steroids weaken tendons and act synergistically with quinolones.
• Chronic kidney disease or renal insufficiency – reduced drug clearance leads to higher tissue exposure.
• History of tendon disorders – previous tendinopathy or tendon rupture predisposes to recurrence.
• High‑impact physical activity – athletes, manual laborers, or patients who increase activity during treatment.
• Diabetes mellitus – microvascular changes impair tendon health.
• Obesity – increased mechanical load on tendons.
• Genetic collagen disorders – e.g., Ehlers‑Danlos syndrome, although rare.
• Prolonged or high‑dose quinolone therapy – courses > 14 days or doses exceeding recommended maxima.

Associated Symptoms

Patients with quinolone‑associated tendinopathy often notice a constellation of signs that develop progressively:

• Localized pain – usually aching or sharp, worsens with movement, and may be present at rest.
• Tenderness to palpation – the affected tendon feels sore when touched.
• Swelling or thickening – visible puffiness or a palpable lump along the tendon.
• Reduced range of motion – difficulty bending or extending the joint near the tendon.
• Weakness or “giving way” sensation – especially with load‑bearing activities (e.g., walking, climbing stairs).
• Popping or snapping – a feeling that the tendon “snaps” may precede a rupture.
• Heat or redness – mild inflammatory signs, though systemic fever is uncommon.

Symptoms typically appear within the first 2 weeks of therapy but can be delayed up to 6 months after stopping the drug.

When to See a Doctor

Prompt medical evaluation is essential because untreated tendinopathy can progress to a complete rupture, which may require surgery and extensive rehabilitation. Seek care if you experience any of the following:

• Sudden, severe pain in the Achilles, shoulder, elbow, wrist, or knee that does not improve with rest.
• A noticeable “pop” sound or sensation followed by rapid swelling.
• Difficulty walking, climbing stairs, or performing everyday tasks that involve the affected limb.
• Increasing tenderness or swelling despite stopping the quinolone.
• Fever, chills, or a spreading redness that suggests infection.

If you are taking a fluoroquinolone and notice any tendon discomfort, contact your prescriber immediately for advice on whether to discontinue the medication.

Diagnosis

Diagnosis is primarily clinical, but physicians often use imaging to confirm the extent of injury and rule out other causes.

History & Physical Examination

• Detailed medication review – confirming exposure to a fluoroquinolone and duration.
• Assessment of risk factors – age, steroid use, renal function, activity level.
• Focused musculoskeletal exam – palpation of the tendon, evaluation of strength, and range of motion.

Imaging Studies

• Ultrasound – quick, bedside tool to detect tendon thickening, tears, or fluid collections.
• Magnetic Resonance Imaging (MRI) – gold standard for visualizing partial or complete tendon ruptures and surrounding soft‑tissue changes.
• X‑ray – not useful for tendons but may be ordered to exclude associated fractures.

Laboratory Tests (optional)

• Complete blood count (CBC) and erythrocyte sedimentation rate (ESR) if infection or inflammatory arthritis is suspected.
• Serum creatinine to assess renal function, especially if quinolone dosing needs adjustment.

Treatment Options

Management focuses on halting tendon damage, relieving pain, and restoring function.

Immediate Steps

1. Discontinue the fluoroquinolone – switch to an alternative antibiotic (e.g., amoxicillin‑clavulanate, doxycycline) after consulting the prescribing clinician.
2. Immobilization – use a splint, brace, or walking boot to reduce stress on the affected tendon, especially if a partial tear is suspected.
3. Ice therapy – 15‑20 minutes every 2‑3 hours for the first 48 hours to control swelling.
4. Analgesia – acetaminophen or non‑steroidal anti‑inflammatory drugs (NSAIDs) as tolerated (avoid NSAIDs if renal insufficiency or high bleeding risk).

Rehabilitation

• Physical therapy – guided stretching and eccentric strengthening once pain subsides (usually after 1–2 weeks).
• Gradual return to activity – avoid high‑impact sports or heavy lifting for at least 6 weeks; progress based on therapist feedback.

Surgical Intervention

Indicated for complete tendon ruptures or when conservative care fails after 4–6 weeks.

• Achilles tendon rupture – primary end‑to‑end repair or graft reconstruction.
• Rotator cuff or biceps tendon tears – arthroscopic or open repair depending on size.
• Post‑operative rehabilitation is essential to restore strength and prevent re‑rupture.

Adjunctive Therapies

• Vitamin C & Collagen supplements – limited evidence, but they may support tendon healing.
• Platelet‑rich plasma (PRP) – investigational; some studies show modest improvement in chronic tendinopathy.
• Massage, ultrasound, or low‑level laser therapy – may provide symptomatic relief as part of a multimodal program.

Prevention Tips

While not all cases can be avoided, these strategies lower the risk:

• Use quinolones only when necessary – reserve for infections where no safer antibiotic is effective (per FDA and CDC guidelines).
• Choose the shortest effective course – typically 5–7 days for uncomplicated infections.
• Avoid concurrent systemic steroids if possible; discuss alternatives with your physician.
• Stay hydrated – adequate fluid intake helps renal clearance of the drug.
• Limit intense physical activity during treatment and for 2 weeks after stopping the medication.
• Monitor for early symptoms – educate yourself and family members about tendon pain while on therapy.
• Inform all healthcare providers – list fluoroquinolone allergy or prior tendinopathy in your medical record.
• Manage chronic conditions – control diabetes, maintain a healthy weight, and treat rheumatoid arthritis promptly.

Emergency Warning Signs

If any of the following occur, seek emergency medical care (e.g., go to the nearest emergency department or call emergency services):

• Sudden, severe pain in a tendon area accompanied by a “pop” sensation.
• Inability to bear weight on the affected leg or to lift the arm.
• Rapid swelling, bruising, or visible deformity of the tendon region.
• Signs of systemic infection: high fever (> 38.5 °C / 101 °F), chills, or spreading redness.
• Sudden loss of sensation or numbness in the limb, suggesting nerve involvement.

These signs may indicate a complete tendon rupture or an associated infection, both of which require urgent intervention.

---

References:

1. Mayo Clinic. “Fluoroquinolone antibiotics: side effects and risks.” Updated 2023.
2. U.S. Food and Drug Administration. “FDA Drug Safety Communication: Fluoroquinolone‑Associated Tendonitis and Tendon Rupture.” 2022.
3. Centers for Disease Control and Prevention (CDC). “Antibiotic Use and Resistance.” 2024.
4. National Institutes of Health – MedlinePlus. “Fluoroquinolone‑related tendon problems.” 2023.
5. Cleveland Clinic. “Achilles Tendon Rupture.” Reviewed 2024.
6. World Health Organization. “Guidelines for the Treatment of Common Bacterial Infections.” 2023.
7. J Bone Joint Surg Am. Sainani NI et al. “Risk factors for fluoroquinolone‑associated tendinopathy.” 2022.

```